Viking Fund Management’s Edwards Lifesciences EW Stock Holding History

Viking Fund Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Hold	20,000	–	–	0.16%	114
2026 Q1	$1.6M	Hold	20,000	–	–	0.16%	117
2025 Q4	$1.71M	Hold	20,000	–	–	0.2%	111
2025 Q3	$1.56M	Hold	20,000	–	–	0.19%	111
2025 Q2	$1.56M	Hold	20,000	–	–	0.21%	102
2025 Q1	$1.45M	Hold	20,000	–	–	0.21%	98
2024 Q4	$1.48M	Hold	20,000	–	–	0.23%	99
2024 Q3	$1.32M	Hold	20,000	–	–	0.21%	100
2024 Q2	$1.85M	Hold	20,000	–	–	0.33%	86
2024 Q1	$1.91M	Hold	20,000	–	–	0.35%	87
2023 Q4	$1.52M	Hold	20,000	–	–	0.3%	92
2023 Q3	$1.39M	Hold	20,000	–	–	0.28%	93
2023 Q2	$1.89M	Hold	20,000	–	–	0.36%	89
2023 Q1	$1.65M	Hold	20,000	–	–	0.32%	95
2022 Q4	$1.49M	Hold	20,000	–	–	0.3%	98
2022 Q3	$1.65M	Hold	20,000	–	–	0.39%	90
2022 Q2	$1.9M	Hold	20,000	–	–	0.44%	90
2022 Q1	$2.35M	Hold	20,000	–	–	0.54%	68
2021 Q4	$2.59M	Hold	20,000	–	–	0.68%	49
2021 Q3	$2.26M	Hold	20,000	–	–	0.66%	54
2021 Q2	$2.07M	Hold	20,000	–	–	0.59%	64
2021 Q1	$1.67M	Buy	20,000 +11,000	+122%	+$930K	0.5%	76
2020 Q4	$821K	Hold	9,000	–	–	0.26%	104
2020 Q3	$718K	Hold	9,000	–	–	0.27%	93
2020 Q2	$622K	Hold	9,000	–	–	0.23%	105
2020 Q1	$566K	Hold	9,000	–	–	0.25%	91
2019 Q4	$700K	Hold	9,000	–	–	0.2%	95
2019 Q3	$660K	Hold	9,000	–	–	0.19%	95
2019 Q2	$554K	Hold	9,000	–	–	0.15%	105
2019 Q1	$574K	Hold	9,000	–	–	0.14%	101
2018 Q4	$460K	Buy	+9,000	New	+$455K	0.13%	107

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Viking Fund Management's EW Position: Q2 2026 in Review

Viking Fund Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 20,000 shares worth $1.81M. The position accounts for 0.16% of the portfolio, ranked #114.

Viking Fund Management first reported a position in EW in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.59M in Q4 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Viking Fund Management held 20,000 shares of Edwards Lifesciences worth $1.81M as of Q2 2026.
Viking Fund Management left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.16% of Viking Fund Management's portfolio in Q2 2026, its #114 holding.
Viking Fund Management first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 31 quarters since.
Viking Fund Management's Edwards Lifesciences position peaked at $2.59M in Q4 2021.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Viking Fund Management's 13F filing for Q2 2026, filed 13 Jul 2026.